September 12, 2018
Foamix Pharma Releases positive phase 3 acne data; stock soars 50% in after hours
Foamix Pharmaceuticals showed its topline results of its third Phase 3 clinical trial (FX2017-22) of FMX101 for the treatment of moderate-to-severe acne.